Anavex Life Sciences Corp (AVXL)

[sokol]

It takes a meeting of the minds to make an agreement or to amend an existing agreement. Both parties must be willing. It is not a unilateral transaction on the part of Missling as some may imply. Moreover, this is not LPC’s first rodeo. To view this as a Missling ploy to take advantage of LPC, an experienced party, is a significant stretch. Everyone knows clinical trials and results are pending. No experienced party enters a $250,000,000 agreement like this without doing its due diligence.